BVS•benzinga•
Bioventus Expects 2025 Sales Of $560M-$570M Versus Consensus Of $554.62M, With Adjusted EPS Of $0.64 to $0.68 Versus Consensus Of $0.55
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 11, 2025 by benzinga